Labetalol Hydrochloride
- Product NDC
- 47781-553
- 11-digit product format
- 477810553
- Labeler code
- 47781
- Product ID
- 47781-553_7f45f847-7bbe-326f-c85a-982ea657bee2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- labetalol hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Alvogen Inc.
- Application
- NDA018716
- Marketing category
- NDA
- Marketing start
- 2018-03-01
- Marketing end
- 0000-00-00
- Substance
- LABETALOL HYDROCHLORIDE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47781-553-01 | 47781055301 | 100 TABLET, FILM COATED in 1 BOTTLE (47781-553-01) | 2018-03-01 | 0000-00-00 | No | No | Current |
| 47781-553-05 | 47781055305 | 500 TABLET, FILM COATED in 1 BOTTLE (47781-553-05) | 2018-03-01 | 0000-00-00 | No | No | Current |